These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12407510)

  • 1. Biochemotherapy for advanced melanoma.
    Keilholz U; Gore ME
    Semin Oncol; 2002 Oct; 29(5):456-61. PubMed ID: 12407510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemotherapy of melanoma.
    Keilholz U
    Forum (Genova); 2003; 13(2):158-65; quiz 189. PubMed ID: 14732882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for intergroup trial E-3695 comparing concurrent biochemotherapy with cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma.
    Flaherty LE
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S15-20. PubMed ID: 10685653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemotherapy of melanoma.
    Flaherty LE; Gadgeel SM
    Semin Oncol; 2002 Oct; 29(5):446-55. PubMed ID: 12407509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined chemoimmunotherapy in metastatic melanoma--is there a need for the double?
    Schrader AJ
    Anticancer Drugs; 2000 Mar; 11(3):143-8. PubMed ID: 10831272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma.
    Buzaid AC; Legha SS
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):23-8. PubMed ID: 7992096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients.
    Ives NJ; Stowe RL; Lorigan P; Wheatley K
    J Clin Oncol; 2007 Dec; 25(34):5426-34. PubMed ID: 18048825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of cytokines in the treatment of advanced melanoma. For the EORTC Melanoma Cooperative Group.
    Keilholz U; Eggermont AM
    Oncology; 2000 Feb; 58(2):89-95. PubMed ID: 10705235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy.
    Anderson CM; Buzaid AC; Sussman J; Lee JJ; Ali-Osman F; Braunschweiger PG; Plager C; Bedikian A; Papadopoulos N; Eton O; Legha SS; Grimm EA
    Melanoma Res; 1998 Apr; 8(2):149-55. PubMed ID: 9610868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemotherapy for melanoma.
    Philip PA; Flaherty LE
    Curr Oncol Rep; 2000 Jul; 2(4):314-21. PubMed ID: 11122859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.
    Johnston SR; Constenla DO; Moore J; Atkinson H; A'Hern RP; Dadian G; Riches PG; Gore ME
    Br J Cancer; 1998 Apr; 77(8):1280-6. PubMed ID: 9579834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials.
    Flaherty LE; Atkins M; Sosman J; Weiss G; Clark JI; Margolin K; Dutcher J; Gordon MS; Lotze M; Mier J; Sorokin P; Fisher RI; Appel C; Du W
    J Clin Oncol; 2001 Jul; 19(13):3194-202. PubMed ID: 11432886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma.
    O'Day SJ; Atkins MB; Boasberg P; Wang HJ; Thompson JA; Anderson CM; Gonzalez R; Lutzky J; Amatruda T; Hersh EM; Weber JS
    J Clin Oncol; 2009 Dec; 27(36):6207-12. PubMed ID: 19917850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma.
    Gibbs P; Iannucci A; Becker M; Allen J; O'Driscoll M; McDowell K; Williams P; Rosse P; Murphy J; Gonzalez R
    Melanoma Res; 2000 Apr; 10(2):171-9. PubMed ID: 10803718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.
    Eton O; Legha SS; Bedikian AY; Lee JJ; Buzaid AC; Hodges C; Ring SE; Papadopoulos NE; Plager C; East MJ; Zhan F; Benjamin RS
    J Clin Oncol; 2002 Apr; 20(8):2045-52. PubMed ID: 11956264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.
    Keilholz U; Conradt C; Legha SS; Khayat D; Scheibenbogen C; Thatcher N; Goey SH; Gore M; Dorval T; Hancock B; Punt CJ; Dummer R; Avril MF; Bröcker EB; Benhammouda A; Eggermont AM; Pritsch M
    J Clin Oncol; 1998 Sep; 16(9):2921-9. PubMed ID: 9738559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of metastasized malignant melanoma].
    Kamanabrou D
    Praxis (Bern 1994); 2001 Mar; 90(10):391-6. PubMed ID: 11305184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemotherapy for advanced melanoma.
    Buzaid AC
    Crit Rev Oncol Hematol; 2002 Oct; 44(1):103-8. PubMed ID: 12399002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases.
    Buzaid AC; Colome M; Bedikian A; Eton O; Legha SS; Papadopoulos N; Plager C; Ross M; Lee JE; Mansfield P; Rice J; Ring S; Lee JJ; Strom E; Benjamin R
    Melanoma Res; 1998 Dec; 8(6):549-56. PubMed ID: 9918417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical results using biochemotherapy as a standard of care in advanced melanoma.
    Chapman PB; Panageas KS; Williams L; Wolchok JD; Livingston PO; Quinn C; Hwu WJ
    Melanoma Res; 2002 Aug; 12(4):381-7. PubMed ID: 12170188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.